Furthermore, the suppression of Th1 and Th17 but not Th2 responses by TIGIT+ Treg was dependent on FGL2.21In vivo, FGL2 was critical in the control of effector T cell expansion by TIGIT+ Treg in lymphopenic hosts and in controlling a number of inflammatory diseases including colitis.21 The gene discussed is FGL2; the disease is colitis.